MetaVia reports obesity drug achieves 9.1% weight loss in phase 1 study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. ACN
8. AZN
9. ORCL
10. HOOD

Go back to MetaVia reports obesity drug achieves 9.1% weight loss in phase 1 study
(NASDAQ: MTVA) Delayed: 1.76 +0.01 (0.57%)
Previous Close $1.75    52 Week High $ 
Open $1.76    52 Week Low $ 
Day High $1.81    P/E N/A 
Day Low $1.76    EPS $ 
Volume 32,752